Wire · opportunities
HHS names 4 senior FDA leaders
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 9 September 2026 · Fusion42 review
HHS has appointed four senior leaders at the FDA including the agency’s first deputy commissioner for technology and artificial intelligence, Jared Seehafer, to lead FDA-wide strategy in technology and AI. Other appointments include new directors for the Centers for Drug Evaluation and Research, Biologics Evaluation and Research, and Tobacco Products.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.
◆ ◆ The Wire takeaway
The FDA's new leadership shift includes a dedicated deputy for AI and technology, signalling accelerated regulatory focus in digital health sectors. You need to engage early on FDA’s evolving approach to AI to align your product roadmap and streamline approval cycles.
◆ Coverage
1 source · 9 Sep 2026
◆ Related on Wire
◆ Topics